Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Ann Neurol. 2013 Jan 29;73(2):236–245. doi: 10.1002/ana.23820

Table 4.

Pooled estimates of risk of amyotrophic lateral sclerosis associated by categories of vitamin C supplement intake

Vitamin C Supplement Non Users <400 mg/day 400–700 mg/day ≥700 mg/day Patrend Pbheterogeneity
Men
     Cases 284 203 96 73
     Multivariate-adjusted HR (95% CI)c 1.00 [ref] 1.08 (0.62–1.87) 1.13 (0.70–1.83) 0.98 (0.60–1.62) 0.90 0.57
Women
     Cases 171 140 69 57
     Multivariate-adjusted HR (95% CI)c 1.00 [ref] 0.86 (0.64–1.17) 1.01 (0.71–1.45) 0.99 (0.67–1.46) 0.45 0.75
Pooled analysis
     Multivariate-adjusted HR (95% CI)c 1.00 [ref] 0.99 (0.72–1.37) 1.13 (0.88–1.45) 1.04 (0.81–1.35) 0.68 0.82
a

Ptrend calculated using median value for each quintile

b

P- value for heterogeneity is calculated from the Q-statistic and is used to quantify differences between studies.

c

Adjused for age (years), sex, smoking status (never, past, current), total vitamin E intake (quartiles), body mass index (<23, 23-<25, 25-<30, ≥30), physical activity (low, average, high), educational level (<high school, high school, >high school), and total calories.